Recursion Pharmaceuticals(RXRX)
Focus: Recursion Pharmaceuticals is a public biotech company specializing in automated, software-based drug discovery with a focus on neurology and rare genetic diseases. The company operates as a platform-driven discovery engine rather than a traditional pipeline-heavy pharma company.
Profile data last refreshed 16m ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
28-6 this month
Cooling — net -6 jobs in 30d
15 added, 21 removed. Slower than typical.
Should You Work at Recursion Pharmaceuticals?
AI assessmentRecursion is a high-risk, high-reward opportunity best suited for technologists and scientists who believe in the platform model and can tolerate 5+ years of cash burn before validation.
Why Work Here
- Cutting-edge platform: Work on proprietary automated drug discovery technology that represents a fundamentally different approach to pharma R&D
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$45M
Pipeline & Clinical Trials
PHASE_1
Clinical Trials (1)
NCT06980116Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Phase 1Help build intelligence for Recursion Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.